CABL001A2001B - LTFU for CABL001AUS08 (CML 26 / 21550)

An Open label Multi-center asciminib roll-over study to assess long-term safety in patients who have completed a Novartis sponsored Asciminib study and are judged by the Investigator to benefit from continued treatment. Protocol No.: CABL001A2001B